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Abstract 
 
Background: The main goals of our study were as follows: (1) to investigate whether the methanolic extract of the new cultivar 
(Gürarslan) of Trigonella foenum graecum L. seeds exhibit antiproliferative effects on the HeLa human cervix carcinoma, Mat-LyLu rat 
prostate carcinoma and 3T3 embryonic mouse fibroblast cell lines, (2) to determine how mitosis and DNA synthesis are affected in 
cancer cells by the extract, and (3) to observe the changes in cell morphology after treatment with the extract.  
Materials and Methods: The effect on cell proliferation of these extracts was detected by using methyl thiazolyl diphenyl tetrazolium 
(MTT) assay. Mitotic index and labelling index was determined using the Feulgen staining and autoradiography methods, respectively.  
Results: Our findings show that the methanolic extract of T. foenum graecum seeds might have antiproliferative properties on the cancer 
cell lines only, but not on the 3T3 embryonic mouse fibroblast cell line.  
Conclusion: Our data show that the new variety of T. foenum graecum may have antitumoral properties.  
 
Keywords: Anticancer effect, Cancer, Fenugreek, Cultivar Gürarslan, Plant extract. 
 
Abbreviations:  MI: Mitotic Index; LI: Labelling Index; NCCs: Normalized cell counts; TM: Methanolic extract of Trigonella foenum 
graecum (cultivar Gürarslan) seeds 
 
  
Introduction 
 
Epidemiological studies show that cancer is the second most common cause of death (after cardiovascular diseases) 
worldwide. According to estimates, the incidence of cancer will continue to increase, and cancer will become the first most common 
cause of death in the near future. For this reason, primary, secondary, and tertiary preventions for cancer are important. Primary 
prevention strategies entail blocking the formation of cancer and implementing precautions against risk factors for cancer. This is 
important from both the human health and economic (i.e., low cost) perspectives. Secondary prevention methods include early diagnosis 
and screening tests for the detection of the stages of cancer beginning at the cellular level, without clinical findings. In tertiary 
prevention, however, symptoms of cancer are present, and mortality can only be reduced with appropriate treatment. Secondary, and 
particularly, tertiary prevention strategies require significant financial funding (Tuncer, 2009). Recently, though the importance of 
primary prevention of cancer has been realized, considering the estimations of increase in the cancer incidence, developing new 
treatment approaches is essential. For instance, obtaining new chemotherapeutics from natural sources (i.e. plants, animals) may supply 
an advantage in terms of cost. Besides, the consumption of some herbal sources with diet may also contribute to primary prevention of 
cancer. Since several decades, many plants and plant derivatives have been used for the treatment of various diseases and as cosmetics 
(Baytop, 1999). In recent years, herbal treatments have become very popular and are being increasingly used by alternative and 
complementary/integrative medical practitioners. Because plants can be easily exploited, their activities should be the focus of scientific 
investigations.  
In this study, we investigated the antitumoral properties of a new variety of Trigonella foenum graecum plant, which have a 
kind of therapeutic uses for humans. T. foenum graecum L. (common name: fenugreek, Family: Leguminosae) is cultivated for its seeds 
in the middle and southeastern Anatolia regions of Turkey, and worldwide (Secmen et al., 1995). It has been reported that the main 
components of fenugreek include fixed oil, mucilage, organic phosphorus compounds, choline, trigonelline, and a saponin, which yields 
diosgenin on hydrolysis (Baytop, 1999). It has been shown that the seeds of T. foenum graecum have blood glucose-reducing (Madar et 
al., 1988; Ali et al., 1995; Al-Habori and Raman, 1998), cholesterol-lowering (Al-Habori and Raman, 1998), antinociceptive (Javan et 
al., 1997), and nematicidal (Zia et al., 2001) effects. They are also used for the treatment of urinary system diseases, including prostate 
disorders and kidney stones, in humans (Ali- Shtayeh et al., 2000). A previous study found that the experimentally induced storage of 
renal calcium oxalate in rats could be cured with the use of T. foenum graecum seeds (Ahsan et al., 1989). 
The aim of our study was to investigate the possible in vitro antitumoral effects of the methanolic extract of T. foenum 
graecum based on the kinetic parameters of the cancer cell lines (i.e. HeLa and Mat-LyLu). The fenugreek seeds used in the experiments 
are improved and registered in Turkey (T. foenum graecum cultivar Gürarslan, registration date: 2004) (Anon, 2010). To our knowledge, 
there was no investigation about the possible antitumoral effects of this cultivar of fenugreek. Therefore, it was selected this new variety 
of fenugreek to evaluate possible in vitro antitumor effects on cancer cells. 
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Materials and Methods 
 Cell culture 
 
In the current study, HeLa (human cervix carcinoma, ATCC number is CCL-2), Mat-LyLu (rat prostate carcinoma, obtained 
from Prof. M.B.A. Djamgoz, Imperial College London) and 3T3 (embryonic mouse fibroblast, obtained from Istanbul University, 
Faculty of Medicine) cell lines were used. HeLa and 3T3 cell lines were cultured in DMEM/F12 (Invitrogen, California, USA) 
[supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen, California, USA), 4 × 105 IU/L penicillin, and 2 ×105 µg/L 
streptomycin (Sigma, St. Louis, USA)], and Mat-LyLu cell line were cultured in RPMI-1640 (Invitrogen, California, USA) 
[supplemented with 1% heat inactivated fetal bovine serum, 1% L-glutamine, and 0.5% dexamethasone (Invitrogen, California, USA)] 
media. The cells were maintained under favorable cell culture conditions at 37oC and 5% CO2 in a humidified chamber.  
 
Preparation of extracts  
 
Certified seeds of T. foenum graecum L. (cultivar Gürarslan) were obtained from Prof. Bilal Gürbüz, Ankara University. The 
seeds were powdered mechanically and extracted with methanol (>99%, Riedel) (1:10 w/v) in an orbital shaker at room temperature for 
24 h. Subsequently, the extracts were liyophilized at –40oC under a vacuum (Edwards, England). 
 
Preparation of test medium  
 
Stock solutions were prepared at a concentration of 10 mg/ml for all extracts dissolved in DMEM/F12 and RPMI-1640 media 
with supplements. These stock solutions were filtered using a disposable filter (Sartorius, Germany) with 0.45 µm or 0.20 µm pore sizes. 
The final concentrations of test media, with methanolic extract of the sample, were 10, 15, 20 and 25 μg/ml. Dilutions were achieved in 
the conditioned media.  
 
Proliferation assay 
 
The effects of the extracts on the proliferation of cell lines were assayed using a tetrazolium reagent. A total of 3 × 104 
cells/well were plated in the cell culture medium in a 96-well plate. At 24 h after plating, the medium in the control dishes was replaced 
with fresh medium (plus supplements). The medium in the test dishes was renewed with fresh test medium of different concentrations. 
In order to determine cell proliferation, absorbances were measured using the MTT method, as previously described (Mosmann, 1983), 
at 24 and 48 h after the addition of the test medium by using an ELISA plate reader (Bio-Tek µQuant, USA). Absorbance and reference 
wavelengths were 570 and 690 nm, respectively. Furthermore, cytotoxicity of the extracts in the 3T3 cell line at maximum 
concentrations was measured using the MTT assay.  
 
Mitotic activity  
 
The mitotic index was measured to observe the effects of the extracts on the mitotic activity of the HeLa and Mat-LyLu cell 
lines. For this purpose, the cells were plated on cover slips and treated with the control and test media for 24 h. After incubation, the 
cells were fixed with 3:1 ratio of ethanol:glacial acetic acid and stained using the Feulgen method (Bancroft et al., 1990). The number 
(n) of cells counted during the different phases of mitosis (late prophase, metaphase, anaphase and telophase) totaled 4000–6000 cells 
(C). All of the slides were evaluated by the same person. The mitotic index (MI%) was calculated using the following formula (Ozalpan, 
2001) : MI = (n/C) × 100. 
 
DNA synthesis 
 
The effect of the extract on DNA synthesis in the cancer cell lines was evaluated using the autoradiography method with 
tritiated thymidine (3H-TdR). The method was conducted as previously described (Baserga, 1995). The cells were plated on cover slips 
and treated with the control and test media for 24 h. At the end of the experiment, all groups were treated with a conditioned medium 
supplemented with 5 µCi/ml 3H-TdR (185 MBq/5 mCi, Amersham, England) for 20 min. at 37oC. Subsequently, the cells were fixed 
with 3:1 ratio of ethanol: asetic acid as previously described and stained by the Feulgen method (Bancroft et al., 1990). The remaining 
radioactive materials, not linked to the DNA, were removed with 2% perchloric acid. For autoradiography, the cells on the slides were 
coated with autoradiographic Hypercoat EM-1 emulsion (Amersham, England) by the dip-coating method. After 8 d of exposure, the 
slides were developed using a Kodak D 19 b developer. The labelled cells (n) per 1000 cells (C) were counted on each slide. The same 
person evaluated all slides by counting at least 4000 cells from each group. The labeling index (LI%) was calculated with the following 
formula (Ozalpan, 2001): LI = (n/C) × 100. 
 
Experimental schedule 
 
In our study, cell kinetics, including proliferation, mitotic activity, and DNA synthesis, of the HeLa and Mat-LyLu cell lines 
were investigated. The 3T3 embryonic mouse fibroblast cell line was used to evaluate the cytotoxic effect of the extracts on normal 
cells. We also conducted morphologic observations in cell lines using light microscopy.  
 
Statistical analysis  
 
The experiments repeated triple times at least. Data obtained from the experiments are presented as the mean of the groups ± 
standard error of means (S.E.M.). Student’s t-test, a comparison test of 2 ratios, was used to compare the data. A p-value of <0.05 was 
considered statistically significant. Analysis were performed on a PC using the MS Office Excel and SPSS 11.0 programs. 
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Results and Discussion  
 
Traditionally, many plants have been used for the treatment of different diseases. Some studies have investigated the effects of  
medicinal plants and their derivatives. Our study describes the possible antitumoral effects of crude extract, which was prepared with the 
methanol extract of T. foenum graecum cultivar Gürarslan. The extract was obtained from a new variety of a cultivated plant in Turkey.  
According to the experimental results, methanolic seed extract of Gürarslan fenugreek (TM) inhibited proliferation of HeLa 
cells, and the inhibition rates typically increased with an increase in concentration. The inhibition at all concentrations for TM were 
statistically significant at 24 h. However, at concentrations of only 20 and 25 µg/ml for TM were statistically significant at 48 h (p < 
0.05). Normalized cell counts (NCCs) of HeLa cells in experimental (TM-treated) groups were reduced by the extract (Table 1, Figure 
1A). The half-maximal (50%) inhibitory concentration (IC50) of TM on cell growth at 48 h was calculated as 84.0 ± 0.34 µg/ml (Figure 
1B). On the other hand, the proliferation of Mat-LyLu prostate cancer cell line was not affected by TM (Table 2, Figure 2). The main 
components of fenugreek seeds were saponin derivatives such as trigonelline (Kinsky et al., 1967), diosgenin, yamogenin (Taylor et al., 
1997) and protodioscin (Hibasami et al., 2003). Hibasami et al. (2003), found that protodioscin, isolated from fenugreek seeds, inhibited 
cell growth of human leukemia HL-60 cell line by inducing apoptosis. Raju et al. (2004), indicated that diosgenin was shown to 
suppress proliferation of HT29 human colon cancer cells. In another study, these researchers showed that diosgenin led to the dose-
dependent inhibition of HCT116 human colon cancer cell line proliferation and induced apoptosis (Raju and Bird, 2007). Moalic et al. 
(2001), showed that diosgenin inhibited proliferation of the human osteosarcoma 1547 cell line through cessation of the cell cycle 
during the G1 phase and the induction of apoptosis. Another group of researchers showed that diosgenin arrested the cell cycle of the 
same cell line and induced apoptosis by increasing expression of the p53 tumor suppressor oncoprotein (Corbiere et al., 2003). In our 
study, we showed that the mitotic activity of HeLa cells was suppressed by the TM at 24 and 48 h. The mitotic index (%) was 
determined as 7.75 ± 1.17 and 5.84 ± 1.27 in the HeLa cell control group at 24 and 48 h, respectively. After TM treatment, mitotic 
activity significantly decreased to 3.19 ± 0.42, and 2.99 ± 0.73 (25 µg/ml of TM) at 24 and 48 h, respectively (p < 0.05) (Figure 3A). In 
addition, the decrease of DNA synthesis of this cell line with TM was statistically significant only at 24 h (Figure 3B). The reason for 
reducing the cell growth and the mitotic activity of HeLa cells by TM, without significant decrease of DNA synthesis at 48 h, might be 
related the doubling time of the cell line. Contrary to HeLa cell line, the mitotic activity of Mat-LyLu cells was not affected by TM, in  
similar with cell proliferation. (Figure 4A). However, DNA synthesis rate (LI%) of this cell line significantly decreased at 48 h after TM 
treatment. The labelling index (%) decreased from 38.3 ± 2.13 (control group) to 25.6 ± 1.27 (25 µg/ml of TM) (Figure 4B). 
Considering the data obtained from this 3 parameters, if the duration of treatment is extended, it may predict that Mat-LyLu cell 
proliferation might decrease. Indeed, Shabbeer et al. (2009), prepared the crude extract of fenugreek with a combination of ethanol, 
hexane, petroleum ether, chloroform, and ethyl acetate, and administered the extract on pancreas (MiaPaCa, HS766T, Panc1, L3.6PL, 
and BXPC3), breast (MCF, MDA-MB-231, T47D, and SKBR3), and prostate (DU145, PC-3, and LNCaP) cancer cell lines, and the 
hTertPrEC human normal prostate cell line for 72 hours. The crude extract inhibited cell proliferation at concentrations of 10 and 15 
µg/ml, whereas it did not have an effect on the hTertPrEC cell line.  
The data indicate that TM did not exhibit cytotoxicity on the proliferation of the 3T3 embryonic mouse fibroblast cell line 
(Figure 5). Vacuoles in the cytoplasm of HeLa (not Mat-LyLu) cells and a disruption of normal patterns, as determined by light 
microscopy, were observed at 24 h after application of TM. An increase in the extract concentrations and treatment duration led to an 
increase in deterioration of HeLa cell patterns. In addition, vacuoles in 3T3 cells appeared, but this appearance occurred to a lesser 
extent and later than that observed for HeLa cells. 
Table 1: The means of Normalized cell counts (±S.E.M.) and inhibition rates (%) of cell proliferation in HeLa cells which treated with 
fenugreek seed extract (TM). 
 Normalized cell counts Inhibition rates (%) of cell proliferation 
 24th hour 48th hour 24th hour 48th hour 
Control 1 1 -- -- 
TM10 0.90 ± 0.03* 1.01 ± 0.04 10.4 ± 2.88* -1.09 ± 0.30 
TM15 0.84 ± 0.01* 0.95± 0.02 15.7 ± 0.95* 4.63 ± 1.82 
TM20 0.87 ± 0.05* 0.85 ± 0.09* 12.6 ± 5.04* 14.7 ± 1.88* 
TM25 0.84 ± 0.05* 0.85 ± 0.03* 16.3 ± 5.03* 15.3 ± 3.11* 
*: Significant difference compared to the control group (p < 0.05). 
Table 2: The means of Normalized cell counts (±S.E.M.) of Mat-LyLu cells which treated with fenugreek seed extract (TM). 
 Normalized cell counts 
 24th hour 48th hour 
Control 1 1 
TM10 1.15± 0.06 1.32 ± 0.05 
TM15 1.14 ± 0.04 1.34 ± 0.09 
TM20 1.12 ± 0.06 1.21 ± 0.04 
TM25 1.07 ± 0.03 1.09 ± 0.03 
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Figure 1: The effects of T. foenum-graecum seed extract (TM) on cell proliferation of HeLa cell line. Data are presented as mean ± 
standard error of the mean (S.E.M.) (A) Normalized cell counts (NCCs) of HeLa cell line after treatment with TM for 24 and 48 h. (B) 
The inhibition rates (%) of HeLa cell proliferation at 48 h. The half-maximal (50%) inhibitory concentration (IC50) is 84.0 ± 0.34 µg/ml.  
*: Significant difference compared to the control group (p < 0.05). 
 
 
Figure 2: Normalized cell counts (NCCs) of Mat-LyLu cell line after treatment with TM for 24 and 48 h. Data are presented as mean ± 
standard error of the mean (S.E.M.). There is no statistically significant difference between TM-treated and control groups. 
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Figure 3: The effects of T. foenum-graecum seed extract (TM) on (A) Mitotic index (MI%) and (B) Labelling index (LI%) values for 
HeLa cells. Data are presented as mean ± standard error of the mean (S.E.M.). Mitotic activity and DNA synthesis were suppressed by 
TM in this cell line.  
*: Significant difference compared to the control group (p < 0.05). 
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Figure 4: The effects of T. foenum-graecum seed extract (TM) on (A) Mitotic index (MI%) and (B) Labelling index (LI%) values for 
Mat-LyLu cells. Data are presented as mean ± standard error of the mean (S.E.M.). TM did not effect the mitotic activity of Mat-LyLu 
cells, but DNA synthesis was suppressed by TM at 48 h after treatment. 
*: Significant difference compared to the control group (p < 0.05). 
 
 
Figure 5: Normalized cell counts (NCCs) of 3T3 and HeLa cell lines at 48 h after treatment with the TM at concentration of 25 µg/ml. 
TM inhibited the proliferation of cancer (HeLa) cells only, but not normal (3T3) cells. 
*: Significant difference compared to the control group (p < 0.05). 
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Conclusions 
 
Our findings can be briefly summarized as follows: 
1) According to the experimental data, the methanolic extracts from T. foenum graecum cultivar Gürarslan seeds inhibited cell 
proliferation and DNA synthesis, and reduced the mitotic index of the HeLa cell line. Moreover, this extract inhibited only DNA 
synthesis in Mat-LyLu prostate cancer cell line.  
2) The methanolic seed extract of this new fenugreek cultivar did not toxic against 3T3 embryonic mouse fibroblast cell line. 
In conclusion, the methanolic seed extract of T. foenum graecum (cultivar Gürarslan) may exhibit antitumor effects, as shown 
by the inhibition of proliferation of the cancer cell lines but not normal cells. Additionally, the antitumor effects may get stronger with 
repeated doses and extended treatment time. In particular, T. foenum graecum seeds can play an important role in the prevention or 
treatment of various cancer types, particularly because they are edible, cultivable, easily accessible and can be combined with 
chemotherapeutics. Therefore, active substances that can inhibit kinetic parameters of the cancer cell lines should be isolated and 
purified from this extract, and the molecular mechanisms underlying the effects of these active substances should be investigated. 
Additional in vitro and in vivo experiments should be conducted using different cancer cell lines. Novel and effective pharmacological 
agents or chemotherapeutics derived from natural resources, such as plants, will have a positive effect on the development of drugs 
when considering the cost of the process and its negative impact on the environment. Therefore, we hope that the results obtained from 
our study will contribute to the development of new pharmacological agents, chemotherapeutics or supplements. 
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